Resectable pancreatic ductal adenocarcinoma
Clinical trials for Resectable pancreatic ductal adenocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Resectable pancreatic ductal adenocarcinoma trials appear
Sign up with your email to follow new studies for Resectable pancreatic ductal adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene test may guide smarter chemo for pancreatic cancer
Disease control Not yet recruitingThis phase II trial tests whether choosing chemotherapy based on a specific gene mutation (SMAD4) can improve outcomes for people with pancreatic cancer that is or may be surgically removable. The SMAD4 gene normally acts as a brake on tumor growth, but when it's mutated, tumors …
Matched conditions: RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Phase 2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug combo aims to outsmart pancreatic cancer before surgery
Disease control Not yet recruitingThis early-phase trial will test whether adding the study drug NP137 to standard chemotherapy (FOLFIRINOX) can change the behavior of pancreatic cancer cells before and after surgery. About 25 people with resectable pancreatic cancer will receive the combination, and researchers …
Matched conditions: RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Phase 1 • Sponsor: Aram Hezel • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC